We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 81-100 of 1,914 results
  1. Use of Real-World Evidence in Regulatory Decisions for Traditional Chinese Medicine: Current Status and Future Directions

    Traditional Chinese medicine (TCM) is a valuable resource unique to China with a long history of human use and clinical practice, which can be...

    Pei Li, Su Wang, Yuwen Chen in Therapeutic Innovation & Regulatory Science
    Article Open access 23 November 2023
  2. Cell cycle arrest-mediated cell death by morin in MDA-MB-231 triple-negative breast cancer cells

    Background

    Morin, a flavonoid extracted from Moraceace family and exhibits several pharmacological activities including anti-cancer activity . ...

    Sushma Maharjan, Yun-Suk Kwon, ... Kyung-Soo Nam in Pharmacological Reports
    Article 16 May 2021
  3. From Print to Screen: Regulatory Considerations to Adopting Innovative Approaches for Patient Information and Safety

    Patient information leaflets (PILs) differ across regulatory jurisdictions—its form and structure are dependent on the regulations it conforms to....

    Winona Rei R. Bolislis, Charlie Mortazavi, ... Thomas C. Kühler in Therapeutic Innovation & Regulatory Science
    Article Open access 09 December 2019
  4. Quantitative Benefit–Risk Assessment: State of the Practice Within Industry

    Background

    Benefit–risk assessments for medicinal products and devices have advanced significantly over the past decade. The purpose of this study was...

    Meredith Y. Smith, Janine van Til, ... Kevin Marsh in Therapeutic Innovation & Regulatory Science
    Article Open access 27 October 2020
  5. Regulatory Reform Outcomes and Accelerated Regulatory Pathways for New Prescription Medicines in Australia

    National Regulatory Authorities (NRAs) globally are facing the challenge of evaluating pharmaceutical products in a speedy manner, whilst...

    Alina Yoffe, Johnson Liu, ... Orin Chisholm in Therapeutic Innovation & Regulatory Science
    Article Open access 21 October 2022
  6. Survey Result for E-labeling Initiatives in Asia

    Under the COVID-19 pandemic, various electronic labeling initiatives have accelerated worldwide in the healthcare and pharmaceutical fields as part...

    Rie Matsui, Koji Yamaguchi, ... Runyi Mo in Therapeutic Innovation & Regulatory Science
    Article Open access 10 October 2022
  7. Regulatory enforcement of the marketing of fixed-dose combinations in India: a case study of systemic antibiotics

    Background

    In India, states have licensed the manufacture of large numbers of fixed-dose combination (FDC) drugs without the required prior approval...

    Petra Brhlikova, Aashna Mehta, ... Habib Hasan Farooqui in Journal of Pharmaceutical Policy and Practice
    Article Open access 10 November 2023
  8. PLANT BIOTECHNOLOGY

    Extensive research is underway worldwide on the production of active plant components from medicinal plants under controlled, reproducible conditions...
    Éva Szöke, Ágnes Kéry, Éva Lemberkovics in From Herbs to Healing
    Chapter 2023
  9. Patient and Public Perceptions in Canada About Decentralized and Hybrid Clinical Trials: “It’s About Time we Bring Trials to People”

    Background

    Little is known about patient and the public perspectives on decentralized and hybrid clinical trials in Canada.

    Methods

    We conducted an...

    Dawn P. Richards, John Queenan, ... Susan Marlin in Therapeutic Innovation & Regulatory Science
    Article Open access 21 June 2024
  10. Evaluation of a Pilot: Inspection Facilitation and Collaboration Using a Mixed Reality Device

    The COVID-19 pandemic forced industry and national regulatory authorities (NRAs) to think about innovative ways to ensure business continuity,...

    Peter Baker, Tamika Cathey, Jared R. Auclair in Therapeutic Innovation & Regulatory Science
    Article Open access 22 November 2023
  11. Don’t Rely on Your Prescription

    Most likely it’s not working for you. When you are prescribed a medicine and take it, you do so in the hope that you will have a benefit from it. Why...
    Chapter 2022
  12. Influence of growth regulators on distribution of trichomes and the production of volatiles in micropropagated plants of Plectranthus ornatus

    The profile of volatile organic compounds, the glandular and non-glandular trichomes of Plectranthus ornatus , obtained by in vitro cultivation, was...

    Helna C. Passinho-Soares, Juceni P. David, ... Moema C. Bellintani in Revista Brasileira de Farmacognosia
    Article Open access 21 November 2017
  13. Bridging the Gap: A Comparative Investigation of Pharmaceutical Excipient Regulations

    Since the awareness of adverse effects associated with pharmaceutical excipients in drug formulations, these excipients are no longer considered...

    Ashwin Mali, Vijaykumar Kuvar, Saily Bharadwaj in Therapeutic Innovation & Regulatory Science
    Article 06 December 2023
  14. On Innovation

    Innovation has become an increasingly common topic in healthcare. Private companies, developers, payers, and regulators are devoting attention toward...

    Article 05 February 2020
  15. Hypericin-Mediated Regulation of miR21 and miR34a and Their Target Genes in MCF7 Breast Cancer Cells

    Hypericin is a polyphenolic compound derived from Hypericum perforatum L., Hypericaceae, that exhibits cytotoxic activity in various cancer cell...

    Raana Norouzi, Sepideh Ghotbzadeh-kermani, Hossein Abbaspour in Revista Brasileira de Farmacognosia
    Article 26 August 2023
  16. Using Bayesian Dynamic Borrowing to Maximize the Use of Existing Data: A Case-Study

    Bayesian Dynamic Borrowing (BDB) designs are being increasingly used in clinical drug development. These methods offer a mathematically rigorous and...

    Dawn Edwards, N. Best, ... A. Fowler in Therapeutic Innovation & Regulatory Science
    Article Open access 01 November 2023
  17. Plant Cell Suspension Culture: Modern Approaches and Problems in Drug Production (Review)

    The review is focused on the current status of plant cell cultivation, prospects for the development of approaches in this field, and the formulation...

    A. A. Shmarova, O. A. Terent’eva, ... N. S. Pivovarova in Pharmaceutical Chemistry Journal
    Article 07 May 2022
  18. Oxytocin quality: evidence to support updated global recommendations on oxytocin for postpartum hemorrhage

    Background

    The use of quality injectable oxytocin effectively prevents and treats postpartum hemorrhage, the leading cause of maternal death...

    Peter Lambert, Michelle P McIntosh, ... Helen Petach in Journal of Pharmaceutical Policy and Practice
    Article Open access 15 May 2020
  19. Targeting Endothelial Progenitor Cells Reparative Potential Via Canonical Wnt/NOX-4 Signaling Pathway in Rats Dyslipidemia: Role of Resveratrol

    Signaling pathways guiding the reparative function of endothelial progenitor cells (EPCs) are complex. Conflicts involve the double-face role of...

    A. Elgeziry, R. Ghazala, ... C. A. Ismail in Pharmaceutical Chemistry Journal
    Article 13 July 2024
  20. Quality Management System in Production of Reference Materials

    The article touches the most relevant aspects of the role of quality management systems (QMSs) in the creation and replenishment of universal bases...

    V. S. Pyzhov, V. I. Gegechkori, ... E. A. Pogrebinskaya in Pharmaceutical Chemistry Journal
    Article 01 May 2024
Did you find what you were looking for? Share feedback.